Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL22733757 | 1.00 | TSHR (0.33) | TSHRALDH1A1LMNATP53TRIM24 | |
| SCHEMBL15879093 | 1.00 | TSHR (0.33) | TSHRALDH1A1LMNATP53TRIM24 | |
| SCHEMBL11315603 | 0.81 | TSHR (0.47) | TSHRALDH1A1LMNATP53CA1 | |
| SCHEMBL6052828 | 0.77 | — | — | |
| SCHEMBL11311761 | 0.74 | CA1 (0.50) | TSHRALDH1A1LMNATP53TRIM24 | |
| SCHEMBL313621 | 0.70 | — | — | |
| SCHEMBL8650878 | 0.69 | CA1 (0.60) | TSHRALDH1A1LMNATP53CA1 | |
| SCHEMBL8651579 | 0.69 | CA1 (0.60) | TSHRALDH1A1LMNATP53CA1 | |
| SCHEMBL11129170 | 0.69 | CA1 (0.60) | TSHRALDH1A1LMNATP53CA1 | |
| SCHEMBL626027 | 0.69 | CA1 (0.60) | TSHRALDH1A1LMNATP53CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388880-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-11742519-B2 | Silicon-based energy storage devices with electrolyte additive compounds | ENEVATE CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-20200388880-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388880-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS | SOST, CA1, DUOX2 | TSHR 4386/4885ALDH1A1 1727/4885LMNA 3760/4885 |
| US-11742519-B2 | Silicon-based energy storage devices with electrolyte additive compounds | SOST, CA1, DUOX2 | TSHR 4386/4885ALDH1A1 1727/4885LMNA 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.